drugset / Trial / NCT03257995
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study is a randomized, double-blind, placebo-controlled, three-period cross-over study in approximately 54 subjects with asthma.
Timeline
- Start
- 2017-09-05
- Primary completion
- 2018-01-17
- Completion
- 2018-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indacaterol | Other / unclassified | 150 ug | Inhaled |